Identità

5-Hydroxy Fluvastatin

Mhux elenkat · C24H26FNO5

01Identità

Lazychem IDLC-03486
CAS RNMhux elenkat
PubChem CID129858577
Molecular formulaC24H26FNO5
Molecular weight427.5 g/mol
IUPAC name(E,3R)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5,5-trihydroxyhept-6-enoic acid
InChIKeyNEMPRSHNUXOXEU-DXRVJIQQSA-N

02Struttura u stereokimika

2D structurePubChem CID 129858577
Two-dimensional chemical structure of 5-Hydroxy Fluvastatin
Two-dimensional structure for the PubChem identity linked to this record. Confirm the identifiers before analytical use.

The parsed structure contains 3 rings, includes aromatic atoms, includes aliphatic carbon, has 1 defined stereocentre, contains at least one halogen atom. These statements are calculated from the published structure string.

Defined stereocentres1
Ring count3
Secondary amines0
Tertiary amines0
SMILESCC(C)N1C2=CC=CC=C2C(=C1/C=C/C(C[C@H](CC(=O)O)O)(O)O)C3=CC=C(C=C3)F
InChIMhux elenkat

03Stereochemistry

The published structure contains 1 defined and 0 unassigned tetrahedral stereocentre. The exact wedge and dash depiction is shown above.

Defined centres1Structure assigned
Unassigned centres0Structure unspecified
Assignment statusFully assignedExact published identity
Tetrahedral upper bound≤ 2Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04Status fl-Indja

Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.

05Ismijiet u relazzjonijiet

API u mediċina prinċipali

Fluvastatin

Impuritajiet u komposti relatati

Ismijiet u relazzjonijiet

    Impuritajiet u komposti relatati

    06Sorsi